176 related articles for article (PubMed ID: 4404957)
1. The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.
Reisner EG; Amos DB
Transplantation; 1972 Oct; 14(4):455-61. PubMed ID: 4404957
[No Abstract] [Full Text] [Related]
2. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
Ray PK; Simmons RL
Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
[No Abstract] [Full Text] [Related]
3. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
Ray PK; Simmons RL
Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
[No Abstract] [Full Text] [Related]
4. The immune reactivity of heterologous antisera against a solubilized human lymphoid membrane component.
Einstein AB; Mann DL; Gordon HG; Fahey JL
Tissue Antigens; 1971; 1(5):209-18. PubMed ID: 5172713
[No Abstract] [Full Text] [Related]
5. Dynamic aspects of the interaction between antibodies and complement at the cell surface.
Sundqvist KG; Svehag SE; Thorstensson RT
Scand J Immunol; 1974; 3(3):237-50. PubMed ID: 4211939
[No Abstract] [Full Text] [Related]
6. Diversity of T cells recognizing transplantation antigens: mechanism of antigen recognition.
Wekerle H; Lanai P; Feldman M
Transplant Proc; 1973 Mar; 5(1):133-6. PubMed ID: 4144457
[No Abstract] [Full Text] [Related]
7. Effect of neuraminidase on serological properties of murine lymphoid cells.
Schlesinger M; Amos BD
Transplant Proc; 1971 Mar; 3(1):895-7. PubMed ID: 4106346
[No Abstract] [Full Text] [Related]
8. Cell growth cycle and expression of histocompatibility antigens on cultured human lymphoid cells.
Ferrone S; Polli EE
Haematologica; 1974 Mar; 59(1):25-37. PubMed ID: 4212983
[No Abstract] [Full Text] [Related]
9. Fate of HL-A antigens and antibodies at the lymphocyte surface.
Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
[No Abstract] [Full Text] [Related]
10. Relation of the neuraminidase-revealed antigens of human lymphocytes and erythrocytes.
Reisner EG
Transplantation; 1975 Apr; 19(4):357-60. PubMed ID: 1171544
[No Abstract] [Full Text] [Related]
11. The cytotoxic reactivity and sialic acid content of human lymphoid cells.
Reisner EG; Flye MW; Chung KS; Amos DB
Tissue Antigens; 1974; 4(1):7-20. PubMed ID: 4545917
[No Abstract] [Full Text] [Related]
12. [The effext of papain, neuraminidase and AET on the behavior of lymphocytes in cytotoxicity tests].
Bube FW; Heumann H; Seegers D; Siebel E
Blut; 1975 Jul; 31(1):21-8. PubMed ID: 1148401
[TBL] [Abstract][Full Text] [Related]
13. Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture.
Ferrone S; Cooper NR; Pellegrino MA; Reisfeld RA
J Exp Med; 1973 Jan; 137(1):55-68. PubMed ID: 4734592
[TBL] [Abstract][Full Text] [Related]
14. The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.
Ray PK; Gewurz H; Simmons RL
Clin Exp Immunol; 1972 Jul; 11(3):441-60. PubMed ID: 5042921
[No Abstract] [Full Text] [Related]
15. [Effects of a heterologous immune serum against bone marrow cells of the mouse].
von Broen B
Acta Biol Med Ger; 1974; 32(6):681-90. PubMed ID: 4153702
[No Abstract] [Full Text] [Related]
16. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
17. Evaluation of C3 receptors on lymphoid cells with different complement sources.
Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
[No Abstract] [Full Text] [Related]
18. Membrane antigens characteristic of human lymphoid cells in established cultures.
Thieme TR; Colombe BW
Tissue Antigens; 1974; 4(3):210-7. PubMed ID: 4137060
[No Abstract] [Full Text] [Related]
19. Murine autoantibodies to a cryptic membrane antigen; possible explanation for neuraminidase-induced increase in cell immunogenicity.
Rosenberg SA; Schwarz S
J Natl Cancer Inst; 1974 Apr; 52(4):1151-5. PubMed ID: 4826586
[No Abstract] [Full Text] [Related]
20. Variables in an assay of soluble human transplantation antigens.
Etheredge EE; Franecki BH; Najarian JS
Tissue Antigens; 1971; 1(3):109-20. PubMed ID: 5170501
[No Abstract] [Full Text] [Related]
[Next] [New Search]